Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 6Neoplasm Metastasis 6Bone Neoplasms 5Breast Neoplasms 3Prostatic Neoplasms 1Osteoporosis 1Hematologic Neoplasms 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Bone Diseases, Metabolic 1Adenocarcinoma 1

Interventions

Gemcitabine 27Fluorouracil 25Oxaliplatin 21Cisplatin 19Leucovorin 17Bevacizumab 16Docetaxel 13Albumin-Bound Paclitaxel 13130-nm albumin-bound paclitaxel 13Paclitaxel 12Capecitabine 12Irinotecan 11Carboplatin 9pembrolizumab 7Nivolumab 7Radiotherapy 6Pemetrexed 6Erlotinib Hydrochloride 6Cyclophosphamide 6Trastuzumab 5Ramucirumab 5Ipilimumab 4Everolimus 4Crizotinib 4Cetuximab 4vandetanib 3trastuzumab deruxtecan 3sargramostim 3folfirinox 3Sorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adenocarcinoma × Ibandronic Acid × Clear all
NCT01077817 2022-02-03

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

Organon and Co

Completed
684,815 enrolled 6 charts
Gastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡